ro.zielinski

TL2 · Uppsala

Contributes reviews on supplier material. Based in Uppsala.

Joined 4 May 2025 · last posted 2d · groups: newcomer-guides

70 posts, newest first. Showing up to 150.

Angle of injection and whether 90 degrees is always right — the long version Replied, post #56 · Practice › Administration · 26 Jul 2026 · 32 likes Worth separating two things that post #52 runs together. The reason Angle of injection is hard to answer is that the obvious measurement and the relevant quantity are…
Hair shedding at month three: mechanism and time course — the long version Replied, post #52 · Practice › Side effects · 22 Jul 2026 · 22 likes I read post #48 twice before replying, because I had assumed the opposite. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other…
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #6 · Sourcing › Red flags · 21 Jul 2026 · 8 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. I looked this up rather…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #74 · Analytics › Home & field testing · 16 Jul 2026 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Reflectance and photometric devices: I would want to see the raw numbers rather than the…
Insomnia at a dose step: reported experiences — the long version Replied, post #45 · Wellbeing › Sleep · 11 Jul 2026 · 4 likes On post #43 — agreed on the reasoning, with one qualification. Vivid dreams are reported here and are not well characterised in the published literature for this class.
A 40-week log with the measurement method stated — what changed since Replied, post #11 · Outcomes › Progress reports · 7 Jul 2026 · 12 likes Adding thanks rather than a view. I do not have a view worth the space.
GLP-1 receptor distribution: central and peripheral Replied, post #85 · Pharmacology › Receptor biology · 7 Jul 2026 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #15 · Sourcing › Payments · 5 Jul 2026 · 16 likes Reading this Payment method thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #3 · Evidence › Journal club · 28 Jun 2026 · 7 likes Post #2 is right about the mechanism and I think understates the practical bit. SUSTAIN 6 has been discussed here with more heat than it deserves, mostly because two…
Asking a follow-up: new topic or new reply? Replied, post #23 · Start Here › How to Ask · 24 Jun 2026 · 2 likes Useful. I had the fact and not the reason, which turns out to be the important half.
The anatomy of a question that gets answered within an hour Replied, post #79 · Start Here › How to Ask · 15 Jun 2026 · 1 like Taking post #78 at face value and following it one step further. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #5 · Compounds › Retatrutide · 14 Jun 2026 · 9 likes That reframing is the whole thing. The facts I already had.
Forced degradation studies: designing one that is informative Replied, post #76 · Analytics › Method validation · 14 Jun 2026 · 8 likes Marking my uncertainty on forced degradation studies explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
Micronutrient adequacy at low total intake Replied, post #78 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 33 likes Post #77 describes the usual case. This is about the unusual one. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #96 · Practice › Storage & stability · 8 Jun 2026 · 0 likes Post #93 is right about the mechanism and I think understates the practical bit. A beyond-use date on a home preparation is an inference rather than a measurement. It…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #66 · Sourcing › Red flags · 5 Jun 2026 · 30 likes Taking post #64 at face value and following it one step further. Pressure to pay outside a normal channel is the practical warning that has nothing to do with chemistry…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #30 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 2 likes My experience of peak-to-trough ratio contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #13 · Pharmacology › Pharmacokinetics · 29 May 2026 · 2 likes If you are new and reading this thread for the answer to Peak-to-trough ratio: the answer is conditional, the conditions are in the third reply, and the rest of the…
Reading a trial's population section before its results Replied, post #55 · Evidence › Trials · 26 May 2026 · 1 like Everything in post #51 holds. The case it does not cover is the one I have. Effect sizes in a trial population reflect adherence achieved under trial conditions, which…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #65 · Evidence › Journal club · 23 May 2026 · 0 likes Distinguishing three things in the indirect comparison discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #29 · Practice › Administration · 18 May 2026 · 5 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. A…
Private prescribing in the UK: what is actually involved Replied, post #12 · Regional › UK & Ireland · 10 May 2026 · 0 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Coming back to: Time to steady state after a dose increase Replied, post #44 · Pharmacology › Pharmacokinetics · 1 May 2026 · 0 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
[2026 update] Currency conversion and the cost you did not see Replied, post #16 · Sourcing › Payments · 23 Apr 2026 · 13 likes Order confirmations that state the lot to be shipped are rare and are the single most useful thing a supplier can put on one.
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #2 · Practice › Storage & stability · 20 Apr 2026 · 2 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Reading it again,…
List price versus negotiated price versus what you pay Replied, post #85 · Access › Pricing · 15 Apr 2026 · 1 like Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
List price versus negotiated price versus what you pay Replied, post #64 · Access › Pricing · 13 Apr 2026 · 0 likes Everything in post #62 holds. The case it does not cover is the one I have. My position on list price versus negotiated price is current rather than settled. I have…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #56 · Analytics › Method validation · 15 Mar 2026 · 1 like Two questions I would want answered before drawing anything from the Robustness data above: how were the cases selected, and what happened to the ones that dropped out.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 28 Feb 2026 · 0 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other.…
Storing lyophilised material long term: what governs the shelf life Replied, post #73 · Practice › Storage & stability · 20 Feb 2026 · 6 likes My position on storing lyophilised material long term is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #54 · Sourcing › Vendor reports · 6 Jan 2026 · 8 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
Tracking that stops updating and then resumes Replied, post #56 · Sourcing › Logistics · 14 Dec 2025 · 0 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Document outcomes rather than forecasting them. A forecast in this category reads…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #87 · Compounds › Oral incretins · 12 Dec 2025 · 19 likes Understood. Thank you for being specific about the limits of it.
Reading SURMOUNT-1 without the press release Replied, post #95 · Compounds › Tirzepatide · 9 Dec 2025 · 12 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Citation sweep results: how many references did not say what was claimed Replied, post #13 · Meta › Wiki maintenance · 4 Dec 2025 · 2 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #7 · Practice › Administration · 3 Dec 2025 · 23 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #76 · Compounds › Other compounds · 25 Nov 2025 · 28 likes This follows post #73 rather than contradicting it. When "no data" is the complete and final answer: if there is no published human data on a compound, that is the…
Availability by country, dated, with primary sources Replied, post #53 · Access › International · 9 Nov 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed availability, as opposed to read about it? The thread is long and I cannot tell.
The headache that turns out to be dehydration Replied, post #31 · Nutrition & Training › Hydration & electrolytes · 22 Oct 2025 · 21 likes Post #28 answers the question as asked. The question underneath it is different. What I would tell a new member reading about headache for the first time: the confident…
Payment mechanics and the recovery options that do not exist Replied, post #74 · Sourcing › Payments · 22 Oct 2025 · 17 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
Pinch or no pinch, and how needle length changes the answer Replied, post #121 · Practice › Administration · 20 Oct 2025 · 0 likes Post #118 is the version of this I will quote in future. One addition. Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the…
Substitution between formats during a shortage Replied, post #74 · Access › Shortages · 13 Oct 2025 · 1 like Bookmarking this. I will come back when I have something worth adding.
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #20 · Analytics › HPLC & UHPLC · 4 Oct 2025 · 1 like On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
Titles that describe the question, not the situation — what changed since Replied, post #31 · Start Here › How to Ask · 20 Sep 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
Persistent vomiting and the threshold for seeking help Replied, post #24 · Safety › Adverse events · 26 Aug 2025 · 16 likes The documentation on persistent vomiting is better than this thread and I say that as someone who has posted in the thread.
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #29 · Practice › Storage & stability · 17 Aug 2025 · 30 likes Post #27 put the caveat in the right place and I want to underline it. The practical version of Freeze-thaw is three sentences long. The rigorous version is three pages…
Comparing my trajectory with the trial curves, carefully Replied, post #36 · Outcomes › Progress reports · 15 Aug 2025 · 28 likes Building on post #35 rather than restating it. Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #26 · Analytics › HPLC & UHPLC · 4 Aug 2025 · 0 likes The version of Resolution and tailing factor that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which…
How to research a compound with no human data without deceiving yourself Replied, post #55 · Compounds › Other compounds · 2 Aug 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
A ten-fold dose error caught before injection — one year on Replied, post #24 · Devices › Syringes & needles · 1 Aug 2025 · 30 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one. I am reporting…
What a 2 ppm match establishes, and what it does not Replied, post #36 · Analytics › Mass spectrometry · 25 Jul 2025 · 0 likes Post #35 answers the question as asked. The question underneath it is different. The honest summary of what a mass result buys you: it narrows the field of what the…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 15 likes Worth separating two things that post #27 runs together. Reading a combination trial came up in a thread eighteen months ago and was answered well. I cannot find it,…
Pre-registering a personal experiment, seriously Replied, post #114 · Research Methods › N-of-1 designs · 4 Jun 2025 · 9 likes Second-hand on pre-registering a personal experiment, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Shakes versus food: a pragmatic assessment — the long version Replied, post #20 · Nutrition & Training › Protein & intake · 9 May 2025 · 0 likes Picking up post #17: that is the part I would want checked first. Shakes versus food is well covered in the tag pages, and the older discussions are better than the…
Adjudicated events and why the definition matters — the long version Replied, post #122 · Evidence › Trials · 27 Apr 2025 · 23 likes I would put moderate confidence on the mainstream reading of Adjudicated events and no more. That is not scepticism for its own sake; it is where the sourcing actually…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #56 · Practice › Interactions · 21 Apr 2025 · 30 likes Narrowing post #55, because the general version has more than one answer. The most defensible general position in this subcategory: identify the plausible mechanism,…
Reading a trial's population section before its results — does this still hold? Replied, post #21 · Evidence › Trials · 19 Apr 2025 · 3 likes Everything in post #17 holds. The case it does not cover is the one I have. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #40 · Compounds › Semaglutide · 15 Mar 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
Holding a dose indefinitely: is there a documented downside? Replied, post #9 · Practice › Dosing & titration · 6 Feb 2025 · 18 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Building a sensible monitoring schedule with your prescriber Replied, post #80 · Clinical › Bloodwork · 22 Dec 2024 · 2 likes Answering the question post #76 raises rather than the one it answers. I have no financial interest in anything named in this thread and I want to say so before I…
Why "any advice?" is the least effective ending for a post Replied, post #120 · Start Here › How to Ask · 8 Dec 2024 · 22 likes Picking up post #119: that is the part I would want checked first. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #50 · Evidence › Journal club · 4 Dec 2024 · 14 likes Adding the measurement that post #47 says would settle it. The bit of SURPASS-2 that nobody enjoys is that the answer changes depending on what you are trying to decide…
UK access routes, dated and sourced — a second dataset Replied, post #10 · Regional › UK & Ireland · 25 Nov 2024 · 1 like MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #32 · Sourcing › Regulatory · 24 Nov 2024 · 4 likes Marking my place. If it changes for me I will come back and say so.
Food noise reducing and the disorientation that can follow Replied, post #34 · Wellbeing › Mental health · 4 Nov 2024 · 6 likes Where I would push back on the food noise consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #37 · Clinical › Comorbidities · 15 Oct 2024 · 19 likes Everything in post #36 holds. The case it does not cover is the one I have. The useful distinction on Hypertension improvement is between what was measured and what was…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #39 · Analytics › Method validation · 25 Sep 2024 · 2 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
About the Introductions category Replied, post #3 · Lounge › Introductions · 17 Aug 2024 · 9 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #28 · Nutrition & Training › Hydration & electrolytes · 6 Aug 2024 · 0 likes Right, and stated more narrowly than I would have dared to state it.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #64 · Evidence › Journal club · 25 Jul 2024 · 17 likes Helpful, and short, which on this subject is harder than long.